Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- PMDA to Establish Approval Standards for More OTC Drugs
October 24, 2005
- MEDICAL DEVICE NEWS IN BRIEF
October 24, 2005
- DIAGNOSTIC NEWS IN BRIEF
October 24, 2005
- 7th IPLS in Madrid Highlights Importance of Partnering
October 24, 2005
- PMDA Announces Measures to Improve Its Services
October 24, 2005
- Control Medical Spending Based on Growth in "Aging-adjusted GDP": Council Experts
October 24, 2005
- UTOBRAIN SEMINAR
October 24, 2005
- Korosho to Include MOF's Viewpoints in Its Healthcare Reform Plan Proposal for FY2006
October 24, 2005
- Pfizer Establishes Website on Research Tools in Collaboration with US NIH
October 24, 2005
- Aripiprazole Recommended for Approval
October 24, 2005
- Are Placebo-controlled Studies Essential for Antidepressants?: Dr Sato of TRC
October 24, 2005
- REGULATORY NEWS IN BRIEF
October 24, 2005
- JHSF Seminars on Drug Discovery Research
October 24, 2005
- Drug Distribution Council Resumes Discussions
October 24, 2005
- JAPIC Seminar on Optimal Healthcare for Patients
October 24, 2005
- Eisai, TorreyPines Announce New Research Program for Alzheimer's Disease
October 24, 2005
- R&D NEWS IN BRIEF
October 24, 2005
- Nippon Kayaku to Make Full Entry into Generic Anticancer Drugs
October 24, 2005
- Correct Knowledge of MS Is Essential: Nihon Schering
October 24, 2005
- BUSINESS NEWS IN BRIEF
October 24, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…